Home › Funds › Livforsakringsbolaget Skandia, Omsesidigt › COR
Livforsakringsbolaget Skandia, Omsesidigt position in COR
CENCORA INC · Health Care
Livforsakringsbolaget Skandia, Omsesidigt reported holding 62,075 shares of COR (CENCORA INC) in its Q2 2026 13F filing — a position valued at US$17.6M, representing 0.56% of its reported portfolio and ranking #46 among its reported holdings. Livforsakringsbolaget Skandia, Omsesidigt has disclosed COR holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Livforsakringsbolaget Skandia, Omsesidigt's COR position evolved
Livforsakringsbolaget Skandia, Omsesidigt first disclosed a stake in COR in Q3 2023 at 9,694 shares (US$1.7M). The position peaked in Q1 2026 at 62,075 shares, worth US$19.5M. Across 12 filings, Livforsakringsbolaget Skandia, Omsesidigt increased the stake 8 time(s), trimmed it 1 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 62,075 shares valued at US$17.6M. Notable position changes include a 62% increase in Q4 2023 (shares rose 18% over the following quarter), a 95% trim in Q2 2025 (shares rose 4% over the following quarter), a 2917% increase in Q3 2025 (shares rose 8% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 9.69K | $1.74M | New |
| Q4 2023 | 15.68K | $3.22M | Add |
| Q1 2024 | 18.98K | $4.61M | Add |
| Q2 2024 | 20.48K | $4.61M | Add |
| Q3 2024 | 27.38K | $6.16M | Add |
| Q4 2024 | 28.57K | $6.42M | Add |
| Q1 2025 | 38.88K | $10.81M | Add |
| Q2 2025 | 1.88K | $562.01K | Reduce |
| Q3 2025 | 56.58K | $17.68M | Add |
| Q4 2025 | 56.58K | $19.11M | Hold |
| Q1 2026 | 62.08K | $19.50M | Add |
| Q2 2026 | 62.08K | $17.57M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About COR and 13F data
COR (CENCORA INC) is a Health Care company. 36 other funds we track also report a position in COR — the largest reported positions include T. Rowe Price Investment Management, Inc. (US$2.10B), Boston Partners (US$1.38B), Carmignac Gestion (US$494.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding COR
- T. Rowe Price Investment Management, Inc. 7.41M sh · $2.10B · Q2 2026
- Boston Partners 4.87M sh · $1.38B · Q2 2026
- Carmignac Gestion 1.75M sh · $494.46M · Q2 2026
- Mawer Investment Management Ltd. 1.49M sh · $421.31M · Q2 2026
- BESSEMER GROUP INC 1.47M sh · $417.15M · Q2 2026
More on Livforsakringsbolaget Skandia, Omsesidigt
FAQ
How long has Livforsakringsbolaget Skandia, Omsesidigt held COR?
Livforsakringsbolaget Skandia, Omsesidigt has disclosed COR holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Livforsakringsbolaget Skandia, Omsesidigt's current position in COR?
As of Q2 2026, Livforsakringsbolaget Skandia, Omsesidigt holds 62.08K shares of COR (CENCORA INC), valued at $17.57M, representing 0.56% of its reported portfolio and ranking #46.
Has Livforsakringsbolaget Skandia, Omsesidigt been buying or selling COR?
In the latest 13F filing (Q2 2026), Livforsakringsbolaget Skandia, Omsesidigt held unchanged its position in COR. The position peaked in Q1 2026 at 62.08K shares.
Which other funds hold COR?
Other major institutional holders of COR include T. Rowe Price Investment Management, Inc., Boston Partners, Carmignac Gestion, among 36 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.